Subscribe To
Cerevance Announces Presentation at the 22nd Society of Chemical Industry / Royal Society of Chemistry Medicinal Chemistry Symposium
BOSTON, Aug. 31, 2023 (GLOBE NEWSWIRE) — Cerevance, a private, clinical-stage drug discovery and development company focused on advancing novel, precision neuroscience therapeutics for central nervous system (CNS) diseases using the company’s proprietary Nuclear Enriched Transcript Sort sequencing (NETSseq) platform, today announced plans to present an oral presentation at the upcoming 22nd Society of Chemical […] The post Cerevance Announces Presentation at the 22nd Society of Chemical Industry...
Read More
Posted: Aug 31 2023, 12:30
Author Name: forextv
Views: 111656